Head and Neck Squamous Cell Carcinomas Clinical Trials

8 clinical trials for Head and Neck Squamous Cell Carcinomas across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors — RECRUITING · PHASE1
• Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I) — RECRUITING · PHASE3
• A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC — RECRUITING · PHASE2
• PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors — TERMINATED · PHASE1
• Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01) — ACTIVE_NOT_RECRUITING · PHASE2
• Myeloprotection With Trilaciclib in Pan-cancer Population — NOT_YET_RECRUITING · PHASE2
• Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma — OTHER · PHASE2
• Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients — COMPLETED · NA

Refine this search